SSRIs in the treatment of depression in Parkinson's disease
โ Scribed by A. F. G. Leentjens; F. W. Vreeling; G.-J. Luijckx; F. R. J. Verhey
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 50 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0885-6230
- DOI
- 10.1002/gps.865
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Although antidepressant medications are commonly used to treat depression in Parkinson's disease (PD), little information is available regarding their safety and efficacy in this condition. Sertraline is a relatively selective serotonin reuptake inhibitor with some dopamine reuptake inh
## Abstract ## Objective It is estimated that 40% of patients with Parkinson's disease (PD) are clinically depressed, however, little is known about the frequency and associated features of subthreshold depression in PD. The current study sought to determine the prevalence of subthreshold depressi
Parkinson's disease (PD) is a disabling neurodegenerative condition commonly complicated by the existence of comorbid depression. The prevalence rates of depression in this patient group have been reported to be as high as 40%. Currently, depression in PD is undertreated; there have been few control
## Abstract To assess the patterns of drug use in Parkinson's disease in Spain, information about the clinical characteristics and current treatment of 1,803 parkinsonian patients was obtained from a nationwide survey, involving 241 physicians with practice based on the different assistance levels